Cover Image
市場調查報告書

LTT Bio-Pharma Co., Ltd. - 產品平台分析

LTT Bio-Pharma Co., Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 256018
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
LTT Bio-Pharma Co., Ltd. - 產品平台分析 LTT Bio-Pharma Co., Ltd. - Product Pipeline Review - 2014
出版日期: 2014年07月22日 內容資訊: 英文 27 Pages
簡介

LTT Bio-Pharma Co., Ltd.是致力於研究·開發藥物及藥物輸送技術的生物科技企業。

本報告提供LTT Bio-Pharma Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

LTT Bio-Pharma Co., Ltd. 的基本資料

LTT Bio-Pharma Co., Ltd. 概要

  • 主要資訊
  • 企業資料

LTT Bio-Pharma Co., Ltd. :R&D概要

  • 主要的治療範圍

LTT Bio-Pharma Co., Ltd. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 藥物研發中的產品/聯合治療模式

LTT Bio-Pharma Co., Ltd. :藥物簡介

  • dzecraprost
  • PC-SOD
  • G-CSF SR
  • LT-0101
  • LT-0201
  • LT-0301

LTT Bio-Pharma Co., Ltd. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

LTT Bio-Pharma Co., Ltd. :暫停中的計劃

LTT Bio-Pharma Co., Ltd. :總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05312CDB

Summary

Global Markets Direct's, 'LTT Bio-Pharma Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the LTT Bio-Pharma Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of LTT Bio-Pharma Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of LTT Bio-Pharma Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of LTT Bio-Pharma Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the LTT Bio-Pharma Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate LTT Bio-Pharma Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of LTT Bio-Pharma Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the LTT Bio-Pharma Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of LTT Bio-Pharma Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of LTT Bio-Pharma Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of LTT Bio-Pharma Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • LTT Bio-Pharma Co., Ltd. Snapshot
    • LTT Bio-Pharma Co., Ltd. Overview
    • Key Information
    • Key Facts
  • LTT Bio-Pharma Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • LTT Bio-Pharma Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • LTT Bio-Pharma Co., Ltd. - Pipeline Products Glance
    • LTT Bio-Pharma Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • LTT Bio-Pharma Co., Ltd. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • LTT Bio-Pharma Co., Ltd. - Drug Profiles
    • ecraprost
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PC-SOD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • G-CSF SR
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LT-0101
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LT-0201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LT-0301
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • LTT Bio-Pharma Co., Ltd. - Pipeline Analysis
    • LTT Bio-Pharma Co., Ltd. - Pipeline Products by Target
    • LTT Bio-Pharma Co., Ltd. - Pipeline Products by Route of Administration
    • LTT Bio-Pharma Co., Ltd. - Pipeline Products by Molecule Type
    • LTT Bio-Pharma Co., Ltd. - Pipeline Products by Mechanism of Action
  • LTT Bio-Pharma Co., Ltd. - Dormant Projects
  • LTT Bio-Pharma Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • LTT Bio-Pharma Co., Ltd., Key Information
  • LTT Bio-Pharma Co., Ltd., Key Facts
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Indication, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Stage of Development, 2014
  • LTT Bio-Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • LTT Bio-Pharma Co., Ltd. - Phase II, 2014
  • LTT Bio-Pharma Co., Ltd. - Discovery, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Target, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Route of Administration, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Molecule Type, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
  • LTT Bio-Pharma Co., Ltd. - Dormant Developmental Projects,2014

List of Figures

  • LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Stage of Development, 2014
  • LTT Bio-Pharma Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Target, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
  • LTT Bio-Pharma Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top